In the latest trading session, 4.67 million Ensysce Biosciences Inc (NASDAQ:ENSC) shares changed hands as the company’s beta touched 0.84. With the company’s most recent per share price at $0.20 changing hands around $0.02 or 9.73% at last look, the market valuation stands at $2.71M. ENSC’s current price is a discount, trading about -930.0% off its 52-week high of $2.06. The share price had its 52-week low at $0.14, which suggests the last value was 30.0% up since then. When we look at Ensysce Biosciences Inc’s average trading volume, we note the 10-day average is 0.73 million shares, with the 3-month average coming to 1.89 million.
Analysts gave the Ensysce Biosciences Inc (ENSC) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended ENSC as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ensysce Biosciences Inc (NASDAQ:ENSC) trade information
Instantly ENSC is in green as seen in intraday trades today. With action 14.76%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -81.59%, with the 5-day performance at 14.76% in the green. However, in the 30-day time frame, Ensysce Biosciences Inc (NASDAQ:ENSC) is -39.45% down. Looking at the short shares, we see there were 0.18 million shares sold at short interest cover period of 0.54 days.
Ensysce Biosciences Inc (ENSC) estimates and forecasts
Data shows that the Ensysce Biosciences Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -63.94% over the past 6 months, a 69.51% in annual growth rate that is considerably higher than the industry average of 17.20%.
The 2024 estimates are for Ensysce Biosciences Inc earnings to increase by 76.33%.
ENSC Dividends
Ensysce Biosciences Inc is expected to release its next quarterly earnings report on 2024-Nov-07.
Ensysce Biosciences Inc (NASDAQ:ENSC)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.54% of Ensysce Biosciences Inc shares while 4.42% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 4.48%. There are 4.42% institutions holding the Ensysce Biosciences Inc stock share, with PLANTE MORAN FINANCIAL ADVISORS, LLC the top institutional holder. As of 2024-06-30, the company held 0.0004% of the shares, roughly 20.0 ENSC shares worth $10.0.
Among Mutual Funds, the top two as of Aug 31, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. With 43.23 shares estimated at $8663.0 under it, the former controlled 0.31% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.13% of the shares, roughly 18.18 shares worth around $3642.0.
